Nintedanib is an antifibrotic agent available as nintedanib 150mg to treat idiopathic pulmonary fibrosis (IPF), chronic fibrosing interstitial lung diseases, and the sclerosis-related lung disease of the systemic sclerosis. It functions by reducing the rate of scarring of the lungs and contributes to the lung functioning in the long term. Nintedanib 150 mg is usually prescribed by doctors as long-term management of the disease to slow down the progression of lung functions.
Dosage Options
In certain circumstances, the physicians can also modify the treatment to Nintedanib 100 mg depending on the side effects or tolerance of the patients. The choice of dose is related to personal health status and therapy reaction.
Cost & Availability
Nintedanib price is often compared by patients to get cheap treatment with reputable sources. A healthcare professional should consider that to receive effective respiratory care, Nintedanib 150 mg must be taken correctly, controlled, and safe prior to commencing the therapy.
read more..